SERUM FOLATE AND BIRTH OUTCOMES: DTG VS EFV TRIAL EVIDENCE IN SOUTH AFRICA
Dolutegravir (DTG) exposure was associated with a 5.4 fold higher risk of neural tube defects (NTDs) in the Botswana Tsepamo study. The mechanism underlying this potential association is unknown. Potentially, effects of DTG on folate metabolism, especially a lowering of levels, could account for these findings. We hypothesized that antiretroviral regimen could affect serum folate…